On October 21st, the South African Health Products Regulatory Authority (SAHPRA) made a groundbreaking announcement, approving Lenacapavir. We had an interview with Monwabisi Mabasa, Gauteng Chairperson of the Treatment Action Campaign, an organization that has been tirelessly advocating for universal access to HIV treatment. In our discussion, we explored their remarkable journey and the significance of this revolutionary new treatment that could change the game for thousands of lives.